Non-invasive assessment of microvascular dysfunction in patients with microvascular angina.

BACKGROUND We aimed to evaluate the microvascular function in patients with microvascular angina (MVA) by assessing 1) the endothelial glycocalyx barrier properties using sublingual microscopy, and 2) the myocardial perfusion reserve using cardiovascular magnetic resonance (CMR) imaging. METHODS Sublingual microscopy was performed in 13 MVA patients (angina pectoris, ST-depression on treadmill testing, normal coronary angiogram) and compared with 2 control groups of 13 volunteers and 14 patients with known obstructive coronary artery disease (CAD). To test the glycocalyx-mediated microvascular responsiveness, the erythrocyte perfused boundary region (PBR) was assessed at baseline and after nitroglycerin challenge. RESULTS The baseline PBR of MVA patients was similar to controls with CAD (p=0.72), and larger than in volunteers (p=0.02). Only the volunteers demonstrated a significant increase in PBR after nitroglycerin (p=0.03). In the 13 MVA patients, adenosine stress CMR perfusion imaging was performed. Although a significant increase in myocardial perfusion was observed in both the subendocardium and subepicardium during stress, the subendocardial perfusion reserve was significantly lower (p=0.02). The PBR responsiveness of the sublingual microvasculature showed a strong correlation with the transmural myocardial perfusion reserve (r=0.86, p<0.001). CONCLUSIONS Patients with MVA can be characterized by microvascular glycocalyx dysfunction using sublingual microscopy. The strong correlation between sublingual PBR responsiveness and myocardial perfusion reserve suggests that the glycocalyx may play an important role in the regulation of microvascular volume for myocardial perfusion and supports the concept of impaired glycocalyx barrier properties in MVA.

[1]  S. Plein,et al.  Endocardial and epicardial myocardial perfusion determined by semi-quantitative and quantitative myocardial perfusion magnetic resonance , 2012, The International Journal of Cardiovascular Imaging.

[2]  C. Ince,et al.  Sidestream Dark Field (SDF) imaging: a novel stroboscopic LED ring-based imaging modality for clinical assessment of the microcirculation. , 2007, Optics express.

[3]  R. Cannon,et al.  "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. , 1988, The American journal of cardiology.

[4]  M. Nieuwdorp,et al.  Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus , 2010, Diabetologia.

[5]  F. Hanley,et al.  Regulation of transmural myocardial blood flow. , 1985, Journal of biomechanical engineering.

[6]  K. Takeda,et al.  Regional myocardial perfusion reserve determined using myocardial perfusion magnetic resonance imaging showed a direct correlation with coronary flow velocity reserve by Doppler flow wire. , 2009, European heart journal.

[7]  T. Ichihara,et al.  Quantitative analysis of first‐pass contrast‐enhanced myocardial perfusion MRI using a patlak plot method and blood saturation correction , 2009, Magnetic resonance in medicine.

[8]  J. Kastelein,et al.  Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. , 2006, Diabetes.

[9]  A. van Rossum,et al.  Is subendocardial ischaemia present in patients with chest pain and normal coronary angiograms? A cardiovascular MR study. , 2007, European heart journal.

[10]  Filippo Crea,et al.  Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. , 2008, Journal of the American College of Cardiology.

[11]  J. Spaan,et al.  Acute attenuation of glycocalyx barrier properties increases coronary blood volume independently of coronary flow reserve. , 2010, American journal of physiology. Heart and circulatory physiology.

[12]  B. Reglin,et al.  Coronary microcirculatory pathophysiology: can we afford it to remain a black box? , 2016, European heart journal.

[13]  Filippo Crea,et al.  Angina pectoris and normal coronary arteries: cardiac syndrome X , 2004, Heart.

[14]  J. Spaan,et al.  Bradykinin‐ and sodium nitroprusside‐induced increases in capillary tube haematocrit in mouse cremaster muscle are associated with impaired glycocalyx barrier properties , 2008, The Journal of physiology.

[15]  J. Francis,et al.  Patients With Syndrome X Have Normal Transmural Myocardial Perfusion and Oxygenation: A 3-T Cardiovascular Magnetic Resonance Imaging Study , 2012, Circulation. Cardiovascular imaging.

[16]  P. Boesiger,et al.  Dynamic contrast‐enhanced myocardial perfusion MRI accelerated with k‐t sense , 2007, Magnetic resonance in medicine.

[17]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.

[18]  Guang-Zhong Yang,et al.  Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. , 2002, The New England journal of medicine.

[19]  M. Koopman,et al.  Damage of the endothelial glycocalyx in dialysis patients. , 2012, Journal of the American Society of Nephrology : JASN.

[20]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  J. Staals,et al.  Sublingual Microvascular Glycocalyx Dimensions in Lacunar Stroke Patients , 2013, Cerebrovascular Diseases.

[22]  Piotr J Slomka,et al.  Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease. , 2011, JACC. Cardiovascular imaging.

[23]  R. Heine,et al.  Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. , 2006, Diabetes.

[24]  Y. Lanir,et al.  Why is the subendocardium more vulnerable to ischemia? A new paradigm. , 2011, American journal of physiology. Heart and circulatory physiology.

[25]  T. Annecke,et al.  Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. , 2010, Cardiovascular research.

[26]  N. Wilke,et al.  Reduced myocardial perfusion reserve and transmural perfusion gradient in heart transplant arteriopathy assessed by magnetic resonance imaging. , 2003, Journal of the American College of Cardiology.

[27]  Hans Vink,et al.  Endothelial glycocalyx: sweet shield of blood vessels. , 2007, Trends in cardiovascular medicine.

[28]  R. de Mutsert,et al.  Deeper Penetration of Erythrocytes into the Endothelial Glycocalyx Is Associated with Impaired Microvascular Perfusion , 2014, PloS one.

[29]  Debiao Li,et al.  Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome Evaluation. , 2015, Circulation. Cardiovascular imaging.

[30]  Hans Vink,et al.  The endothelial glycocalyx: a potential barrier between health and vascular disease , 2005, Current opinion in lipidology.

[31]  J. Lima,et al.  Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study , 2010, Arthritis research & therapy.

[32]  E. Nagel,et al.  High-resolution magnetic resonance myocardial perfusion imaging at 3.0-Tesla to detect hemodynamically significant coronary stenoses as determined by fractional flow reserve. , 2011, Journal of the American College of Cardiology.

[33]  Jeroen J. Bax,et al.  2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.

[34]  H. Vink,et al.  Agonist-induced impairment of glycocalyx exclusion properties: contribution to coronary effects of adenosine. , 2010, Cardiovascular research.

[35]  J. Hoffman,et al.  Transmural myocardial perfusion. , 1987, Progress in cardiovascular diseases.

[36]  G. Lanza,et al.  Cardiac syndrome X: a critical overview and future perspectives , 2005, Heart.

[37]  D. Berman,et al.  Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. , 2011, JACC. Cardiovascular imaging.